fig1

Figure 1. (1A) Total number of dead embryos of X. laevis after exposure 96 h to control, spirulina 10 mgL^-1, DCF 149 µgL^-1, DCF+S 2 (diclofenac 149 µgL^-1 + spirulina 2 mgL^-1), DCF+S 4 (diclofenac 149 µgL^-1 + spirulina 4 mgL^-1), DCF+S 10 (diclofenac 149 µgL^-1 + spirulina 10 mgL^-1); (1B) total number of Xenopus leavis embryos with malformation, after exposure 96 h to control, spirulina 10 mgL^-1, diclofenac 149 µgL^-1, DCF+S 2 (diclofenac 149 µgL^-1 + spirulina 2 mgL^-1), DCF+S 4 (diclofenac 149 µgL^-1 + spirulina 4 mgL^-1), DCF+S 10 (diclofenac 149 µgL^-1 + spirulina 10 mgL^-1). Significant differences relative to: *: control; A: spirulina; B: DCF; C: DCF+S 2; D: DCF+S 4; E: DCF+S 10 (One-way ANOVA and Fisher’s test, P < 0.05).